Stem Cell Institute Symposium to Explore Bone and Cartilage Growth and Repair

Osteoblast depositing bone matrix

The UCSF Institute for Stem Cell and Tissue Biology's Program in Craniofacial and Mesenchymal Biology will host a major symposium on the Parnassus campus Friday, March 17, titled "Mesenchymal Stem Cells and Skeletal Biology." The event will bring together scientists who are leaders in the study of the development and growth of the body's skeletal tissues - bones and cartilage - and will provide a forum for presenting the latest advances in the field. Understanding Paves Way for Repair and Replacement
Scientists have made significant progress in understanding the biology of the cells that give rise to skeletal tissues, information that is critical for understanding skeletal diseases such as craniofacial (cranium and face) anomalies, osteoarthritis and osteoporosis. Based on these insights, scientists are now working in the lab to develop cell-based therapies aimed at repairing or replacing bone and cartilage. "We have learned a lot about how skeletal tissues are formed - how they normally develop and what sometimes goes wrong, leading to skeletal diseases," says Rik Derynck, director of the UCSF Program in Craniofacial and Mesenchymal Biology and co-director of the UCSF Institute for Stem Cell and Tissue Biology. "Given this knowledge, the time is approaching when we will attempt to engineer skeletal tissues to replace damaged or missing tissue in patients." Mesenchymal stem cells form the basis of all skeletal tissues. In fact, depending on their location in the body, they give rise to bone, cartilage, muscle, fat and connective tissue. Scientists have identified many of the molecular steps and intracellular signals that prompt the cells to begin to specialize as bone and cartilage cells.
In experiments in the laboratory of Rik Derynck, researchers have successfully transformed the fat cells of mice (left) to bone cells.
"In the lab, the knowledge is now there to take undifferentiated mesenchymal stem cells and engineer them to convert into cells that deposit bone or cartilage," says Derynck. From Cleft Palates to Arthritis
This strategy could be used to treat a range of needs, from replacing deteriorating cartilage in arthritis, to repairing cleft palates more effectively, to replacing bone that has been surgically removed to combat bone metastases to the jaw. Clinical trials of such cell-based therapies could begin within five years, he says. "We're at an extremely exciting stage in the evolution of the field," says Derynck. "The upcoming symposium will provide a snapshot of where we are and where we're going." The symposium is co-organized by UCSF's Caroline Damsky, professor of cell and tissue biology, Rik Derynck and Richard Schneider, assistant professor of orthopaedic surgery.

Mesenchymal Stem Cells and Skeletal Biology Symposium

Friday, March 17, 8:30 a.m. - 5:15 p.m.
UCSF Parnassus Campus, 513 Parnassus Ave., Health Sciences West, Room 302 Map (pdf)

8:30-9:00 a.m. Continental Breakfast

9:00-9:15 a.m. Welcoming Remarks

9:15-10:00 a.m.
Irma Thesleff, Institute of Biotechnology, Viikki Biocenter, University of Helsinki "Signaling networks regulating tooth morphogenesis and cell differentiation"

10:00-10:30 a.m.
Ophir Klein, Department of Pediatrics, UCSF "Sprouting new teeth: regulation of FGF signaling in dental development"

10:30-10:45 a.m. Coffee Break

10:45-11:30 a.m.
Paul Trainor, Stowers Institute for Medical Research, Kansas City, MO "Neural crest stem cells in craniofacial development: Treacher Collins syndrome and regeneration"

11:30 a.m. - 12:15 p.m.
Richard Schneider, Department of Orthopedic Surgery, UCSF "Mesenchymal stem cells and the spatiotemporal regulation of skeletogenesis"

12:15-2:00 p.m. Lunch (self-hosted)

2:00-2:45 p.m.
Jennifer Elisseeff, Department of Biomedical Engineering, Johns Hopkins University "Tissue engineering in craniofacial disease and repair"

2:45-3:30 p.m.
Rik Derynck, Department of Cell and Tissue Biology, UCSF "TGF-beta signaling in mesenchymal differentiation"

3:30-3:45 p.m. Coffee Break

3:45-4:30 p.m.
Ernestina Schipani, Endocrine Unit, Massachusetts General Hospital-Harvard Medical School "Hypoxia and HIF-1 alpha in chondrogenesis"

4:30-5:15 p.m.
Andrew Lassar, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School "Transcriptional regulatory circuits that control chondrocyte plasticity and maturation" Reception immediately following: Mezzanine, School of Nursing

Sponsored by the Program in Craniofacial and Mesenchymal Biology and the UCSF Institute for Stem Cell and Tissue Biology. Supported by the Comprehensive Oral Health Research Center of Discovery, National Institute of Dental and Craniofacial Research. Additional support from UCSF School of Dentistry, UCSF Department of Orthopedic Surgery, Applied Biosystems, Fisher Scientific, JH Technologies/Leica Microsystems and Stryker. Photo: Rik Derynck Laboratory Source: Jennifer O'Brien Links: S is for Stem Cells UCSF and Stem Cells